ACA
DOVA

Avoro Capital Advisors’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Avoro Capital Advisors’s Portfolio DOVA Stock Details DOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-125,000
Closed -$3.39M – 64
2018
Q1 		$3.39M Buy
+125,000
New +$3.74M 0.16% 42

Other funds holding DOVA

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NC
Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Avoro Capital Advisors's DOVA Position: Q2 2018 in Review

Avoro Capital Advisors sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q2 2018, closing a stake of 125,000 shares — an estimated $3.39M sold.

Avoro Capital Advisors first reported a position in DOVA in Q1 2018 and held it in 1 quarter. The position peaked at $3.39M in Q1 2018. 60 funds tracked by Wall St. Rank hold DOVA as of Q2 2018.

  • Avoro Capital Advisors reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
  • Avoro Capital Advisors sold 125,000 Dova Pharmaceuticals, Inc. Common Stock shares in Q2 2018, an estimated $3.39M.
  • Avoro Capital Advisors first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q1 2018 and held it in 1 quarter.
  • Avoro Capital Advisors's Dova Pharmaceuticals, Inc. Common Stock position peaked at $3.39M in Q1 2018.
  • 60 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q2 2018.

Based on Avoro Capital Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.